Sequencing Multiplex S.L. (Seqplexing) started (emerges) as a Spin-off of INCLIVA (Health Research Institute of Hospital Clínico de Valencia), from the Genetic Diagnosis and Genomics Unit


About Seqplexing

Sequencing Multiplex S.L. (Seqplexing) aims to simplify the methodology of genetic studies with products with a high biotechnological component and high added value. Our solutions simplify procedures by reducing the total time to obtain results, handwork and rationalizing spending

More info

Seqplexing publishes its EOSAL-CNV technology in the book Methods and Molecular Biology

Last April, Seqplexing had the pleasure of being part of volume 2621 of the Methods and Molecular Biology book series, specifically publishing the protocol "EOSAL-CNV for Easy and Rapid Detection of CNVs by Fragment Analysis" ( in the Clinical Applications of Nucleic Acid Amplification block. This publication explains the protocol of the previously patented EOSAL-CNV technology published in Clinical Chemistry (2020 Feb 18). This technique ...


Seqplexing attends Fruit Attraction 2023

Seqplexing attends Fruit Attraction 2023

Fruit Attraction held its 15th edition on October 3, 4 and 5 at IFEMA Madrid. Invited by Biovegen, Carmen Ivorra, our scientific director, together with our commercial representative, had the oppor...

Reconocimientos Seqplexing


Seal of Excellence

Certificate delivered by the European Commission, as the institution managing Horizon 2020, the EU Framework Programme for Research and Innovation 2014-2020


LabScores Report

The European Molecular Genetics Quality Network. Individual Laboratory Report (ILR) - Lab 1792 (Season 2016).